SAGENT

Serial Number 98637116
688

Registration Progress

Application Filed
Jul 8, 2024
Under Examination
Apr 29, 2025
Approved for Publication
Mar 4, 2025
Published for Opposition
Mar 4, 2025
Registered

Trademark Image

SAGENT

Basic Information

Serial Number
98637116
Filing Date
July 8, 2024
Published for Opposition
March 4, 2025
Drawing Code
3

Status Summary

Current Status
Active
Status Code
688
Status Date
Apr 29, 2025
Application
Pending
Classes
005

Rights Holder

SAGENT PHARMACEUTICALS

03
Address
1515 E. Woodfield Road
Suite 1100
SCHAUMBURG, IL 60173

Ownership History

SAGENT PHARMACEUTICALS

Original Applicant
03
SCHAUMBURG, IL

SAGENT PHARMACEUTICALS

Owner at Publication
03
SCHAUMBURG, IL

Legal Representation

Attorney
Tamara A. Miller

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

14 events
Date Code Type Description Documents
Oct 23, 2025 ERTD I TEAS REQUEST TO DIVIDE RECEIVED Loading...
Oct 23, 2025 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Oct 23, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 29, 2025 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Mar 21, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Mar 21, 2025 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Mar 21, 2025 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Mar 4, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
Mar 4, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Feb 26, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Feb 6, 2025 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jan 31, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Jan 30, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jul 8, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceuticals, namely, anesthetics, anti-infectives, antiemetics, antipsychotics, blood modifiers, cardiovasculars, and oncolytics; pre-filled syringes sold filled with cardiovasculars; pharmaceuticals for treatment of cancer; injectable drugs and therapeutic solutions for the treatment of cancer, cardiovascular disease, infections, pain, and psychotic disorders; injectable drugs and therapeutic solutions for the treatment of infections sold in kits comprising pre-filled IV bags with devices for intravenous administration, namely, transfer pins, vials, needles, and adaptors

Additional Information

Design Mark
The mark consists of the word "sagent" in lower case letters, where the "t" in the mark has a bottom extension to the right featuring three separate and equal-sized horizontal rectangles depicted in different shades of grayscale.
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
005